MedPath

Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis

Phase 3
Completed
Conditions
Post-operative Endophthalmitis
Interventions
Procedure: Intravitreal injection of antibiotics
Procedure: Intravitreal injection of Betamethasone + antibiotics
Registration Number
NCT01768078
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

One useful effect of early intravitreal corticotherapy is to diminish inflammatory complications after endophthalmitis, which may cause, at least in part, serious complications (retinal detachment, macular edema) which are, more than the infection, causes of the complications seen after acute endophthalmitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • All patients male or female with no age limit
  • Hospitalized for the diagnosis and treatment of acute endophthalmitis following cataract surgery
  • Who had given their consent after being informed about intravitreal corticotherapy
Exclusion Criteria
  • Patients who refused or were unable to give their consent
  • Prior intravitreal corticotherapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
without corticoidsIntravitreal injection of antibiotics-
with corticoidsIntravitreal injection of Betamethasone + antibiotics-
Primary Outcome Measures
NameTimeMethod
Measure the evolution of visual acuityup to12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

CHU de Besançon

🇫🇷

Besançon, France

CHU de Saint Etienne

🇫🇷

Saint Etienne, France

CHU de Strasbourg

🇫🇷

Strasbourg, France

CHU

🇫🇷

Dijon, France

CHU de Grenoble

🇫🇷

Grenoble, France

CHU de Nancy

🇫🇷

Nancy, France

© Copyright 2025. All Rights Reserved by MedPath